NCCN Guidelines for Patients® | Stages I and II Breast Cancer - page 94

NCCN Guidelines for Patients
®
Stages I and II Breast Cancer, Version 1.2014
92
Index
Index
2
nd
opinion
77
antiestrogen
58–59
aromatase inhibitors
59, 62–63, 64, 67
axillary lymph nodes
7–8, 27–29, 31, 35, 38, 52, 54,
60–61, 73
biopsy
14–16, 25, 70
bone scan
13, 70 –71
breast reconstruction
30–31
chemotherapy
34–48
computed tomograpy (CT) scan
13, 50, 70–71
fertility counseling
16
genetic counseling
16, 70
HER2
14–15, 25, 35, 37–45, 47, 70
hormone receptor
14–15, 25, 35, 37–40, 60–61
hormone therapy
25, 34, 52, 57–64, 67
lumpectomy
22–23, 24–26, 29–31, 52–53
lymph node dissection
27–29, 72
magnetic resonance imaging (MRI)
13, 66, 70–71
mammography
12–13, 23, 25, 66
mastectomy
22–24, 26, 29–30, 72, 80
medical history
10, 66, 70
member institutions
90
nipple replacement
31
panel members
89
pathology report
14
physical exam
10, 25, 28, 66
positron emission tomography (PET) scan
70–71
radiation therapy
24, 26, 49–55, 59, 72–73
stroma
6–8
survivorship
77
symptom control
77
targeted therapy
41
treatment plan
10–19, 70–71, 76–77
volume displacement
30
1...,84,85,86,87,88,89,90,91,92,93 95,96
Powered by FlippingBook